SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

 

WuXi PharmaTech (Cayman) Inc.

(Name of Issuer)

 

 

Ordinary Shares**

American Depositary Shares

(Title of Class of Securities)

 

 

929352102***

(CUSIP Number)

 

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
** Not for trading, but only in connection with the registration of American Depositary Shares each representing 8 ordinary shares.
*** This CUSIP applies to the American Depositary Shares.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

  1  

NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

(ENTITIES ONLY)

 

            Ge Li

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            United States of America

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                35,320,9501

 

  6    SHARED VOTING POWER

 

                0

 

  7    SOLE DISPOSITIVE POWER

 

                35,320,9502

 

  8    SHARED DISPOSITIVE POWER

 

                0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            35,320,950

    
10  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.97%

    
12  

TYPE OF REPORTING PERSON*

 

            IN

    

 

1

Includes (i) 1,296,400 shares held directly by Dr. Ge Li; (ii) 19,499,550 ordinary shares held by J.P. Morgan Trust Company of Delaware, as Trustee of the Ning Zhao 2006 Grantor Retained Annuity Trust, for which Dr. Li is the Investment Advisor and exercises sole dispositive and voting power; and (iii) 14,525,000 ordinary shares issuable upon exercise of options held by Dr. Li.

2

See footnote 1.

Item 1(a)   

Name of Issuer:

 

WuXi Pharmatech (Cayman) Inc. (“Issuer”)

Item 1(b)   

Address of Issuer’s Principal Executive Offices:

 

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s Republic of China

Item 2(a)    Name of Person Filing:
   Ge Li
Item 2(b)    Address of Principal Business Office or, If None, Residence; Citizenship
   Ge Li
   c/o WuXi Pharmatech (Cayman) Inc.
   288 Fute Zhong Road
   Waigaoqiao Free Trade Zone
   Shanghai 200131
   People’s Republic of China
Item 2(c)    Citizenship
   United States of America
Item 2(d)   

Title of Class of Securities:

 

Ordinary shares, par value US$0.02

   American Depositary Shares
Item 2(e)   

CUSIP Number:

 

929352102

Item 3.   

Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c):

 

Not applicable.

 

Item 4.    Ownership
  

(a)    Amount Beneficially Owned:

 

Reporting Person

  

Amount
beneficially

owned:

  

Percent

of class:

  

Sole power

to vote or

direct

the vote:

  

Shared

power to

vote or to

direct

the vote:

  

Sole power to
dispose or to

direct the

disposition of:

  

Shared power
to dispose or to
direct the

disposition of:

Ge Li  

35,320,950

ordinary

shares

   6.97%  

35,320,950

ordinary

shares

   0  

35,320,950

ordinary

shares

   0

 

Item 5.   

Ownership of Five Percent or Less of a Class

 

Not applicable.

Item 6.   

Ownership of More Than Five Percent on Behalf of Another Person

 

Not applicable.

Item 7.    Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
   Not applicable.
Item 8.    Identification and Classification of Members of the Group
   Not applicable.
Item 9.    Notice of Dissolution of Group
   Not applicable.
Item 10.    Certifications
   Not applicable.

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 24, 2008

 

Ge Li

/s/ Ge Li